Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
|
|
15.
|
A highly selective, orally active inhibitor of Janus kinase 2, CEP-33779, ablates disease in two mouse models of rheumatoid arthritis. [electronic resource] by
- Stump, Kristine L
- Lu, Lily D
- Dobrzanski, Pawel
- Serdikoff, Cynthia
- Gingrich, Diane E
- Dugan, Ben J
- Angeles, Thelma S
- Albom, Mark S
- Ator, Mark A
- Dorsey, Bruce D
- Ruggeri, Bruce A
- Seavey, Matthew M
Producer: 20120227
In:
Arthritis research & therapy vol. 13
Availability: No items available.
|
|
16.
|
Depletion of autoreactive plasma cells and treatment of lupus nephritis in mice using CEP-33779, a novel, orally active, selective inhibitor of JAK2. [electronic resource] by
- Lu, Lily D
- Stump, Kristine L
- Wallace, Nate H
- Dobrzanski, Pawel
- Serdikoff, Cynthia
- Gingrich, Diane E
- Dugan, Benjamin J
- Angeles, Thelma S
- Albom, Mark S
- Mason, Jennifer L
- Ator, Mark A
- Dorsey, Bruce D
- Ruggeri, Bruce A
- Seavey, Matthew M
Producer: 20111122
In:
Journal of immunology (Baltimore, Md. : 1950) vol. 187
Availability: No items available.
|